Rachel Cohrs Zhang and John Wilkerson

BioTech

Harris seeks to tie expanded Medicare drug price negotiation to home care policy

WASHINGTON — Vice President Harris is proposing to use cuts to the pharmaceutical industry’s profits in Medicare to fund a home care benefit for people

Rachel Cohrs Zhang and John Wilkerson October 8, 2024

BioTech

JD Vance talked about reinsurance during the VP debate. How does it work?

WASHINGTON — During the vice presidential debate Tuesday, Republican nominee JD Vance at long last provided a bit more clarity to the Trump campaign’s vague

Rachel Cohrs Zhang and John Wilkerson October 3, 2024

BioTech

Q&A: The new CEO of biotech’s top trade group on China, vaccines, and Trump

Rachel Cohrs Zhang Chief Washington Correspondent Rachel Cohrs Zhang reports on the intersection of health policy and business in Washington. She covers Capitol Hill, lobbying,

Rachel Cohrs Zhang and John Wilkerson July 18, 2024

BioTech

BIO’s top lobbyist exits, signaling reorganization

WASHINGTON — The biotech industry’s largest trade group has parted ways with its top lobbyist, the group confirmed to STAT, adding to a recent bout

Rachel Cohrs Zhang and John Wilkerson April 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Rachel Cohrs Zhang and John Wilkerson

Harris seeks to tie expanded Medicare drug price negotiation to home care policy

JD Vance talked about reinsurance during the VP debate. How does it work?

Q&A: The new CEO of biotech’s top trade group on China, vaccines, and Trump

BIO’s top lobbyist exits, signaling reorganization

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe